Treatment of rheumatoid arthritis. A short-term cross-over trial of benorylate (Benoral) tablets

G. Bálint, Myron E. Mavrikakis, Luis A. Hernandez, Marion M. MacLeod

Research output: Contribution to journalArticle

Abstract

A short-term, cross-over therapeutic trial of benorylate (Benoral) tablets was carried out in 18 patients with rheumatoid arthritis. At a dosage of 6 g per day benorylate was shown to be equipotent with 75 mg per day of indomethacin and superior to a placebo in the majority of parameters of assessment.

Original languageEnglish
Pages (from-to)165-168
Number of pages4
JournalClinical Trials Journal
Volume16
Issue number6
Publication statusPublished - 1979

Fingerprint

Cross-Over Studies
Tablets
Rheumatoid Arthritis
Indomethacin
Therapeutics
Placebos
benorilate

Keywords

  • benorylate
  • indomethacin
  • Musculoskeletal diseases C5
  • rheumatoid arthritis

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Treatment of rheumatoid arthritis. A short-term cross-over trial of benorylate (Benoral) tablets. / Bálint, G.; Mavrikakis, Myron E.; Hernandez, Luis A.; MacLeod, Marion M.

In: Clinical Trials Journal, Vol. 16, No. 6, 1979, p. 165-168.

Research output: Contribution to journalArticle

Bálint, G, Mavrikakis, ME, Hernandez, LA & MacLeod, MM 1979, 'Treatment of rheumatoid arthritis. A short-term cross-over trial of benorylate (Benoral) tablets', Clinical Trials Journal, vol. 16, no. 6, pp. 165-168.
Bálint, G. ; Mavrikakis, Myron E. ; Hernandez, Luis A. ; MacLeod, Marion M. / Treatment of rheumatoid arthritis. A short-term cross-over trial of benorylate (Benoral) tablets. In: Clinical Trials Journal. 1979 ; Vol. 16, No. 6. pp. 165-168.
@article{1990112531304857b18541e2be25becb,
title = "Treatment of rheumatoid arthritis. A short-term cross-over trial of benorylate (Benoral) tablets",
abstract = "A short-term, cross-over therapeutic trial of benorylate (Benoral) tablets was carried out in 18 patients with rheumatoid arthritis. At a dosage of 6 g per day benorylate was shown to be equipotent with 75 mg per day of indomethacin and superior to a placebo in the majority of parameters of assessment.",
keywords = "benorylate, indomethacin, Musculoskeletal diseases C5, rheumatoid arthritis",
author = "G. B{\'a}lint and Mavrikakis, {Myron E.} and Hernandez, {Luis A.} and MacLeod, {Marion M.}",
year = "1979",
language = "English",
volume = "16",
pages = "165--168",
journal = "Clinical Trials Journal",
issn = "0009-9325",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Treatment of rheumatoid arthritis. A short-term cross-over trial of benorylate (Benoral) tablets

AU - Bálint, G.

AU - Mavrikakis, Myron E.

AU - Hernandez, Luis A.

AU - MacLeod, Marion M.

PY - 1979

Y1 - 1979

N2 - A short-term, cross-over therapeutic trial of benorylate (Benoral) tablets was carried out in 18 patients with rheumatoid arthritis. At a dosage of 6 g per day benorylate was shown to be equipotent with 75 mg per day of indomethacin and superior to a placebo in the majority of parameters of assessment.

AB - A short-term, cross-over therapeutic trial of benorylate (Benoral) tablets was carried out in 18 patients with rheumatoid arthritis. At a dosage of 6 g per day benorylate was shown to be equipotent with 75 mg per day of indomethacin and superior to a placebo in the majority of parameters of assessment.

KW - benorylate

KW - indomethacin

KW - Musculoskeletal diseases C5

KW - rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=0018706250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018706250&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0018706250

VL - 16

SP - 165

EP - 168

JO - Clinical Trials Journal

JF - Clinical Trials Journal

SN - 0009-9325

IS - 6

ER -